0 Commentarii
0 Distribuiri
571 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Biosimilars and Biologics Market to Hit USD 35.4B by 2030, Says DataM IntelligenceMarket Overview The Biosimilars and Biologics Market size reached US$531.45 billion in 2024 and is expected to reach US$1,773.77 billion by 2033, growing at a CAGR of 14.4% during the forecast period 2025-2033. The Biosimilars and Biologics Market is booming amid rising chronic diseases and aging populations. These therapies provide targeted treatments for complex conditions like cancer and...0 Commentarii 0 Distribuiri 596 Views 0 previzualizare
-
Biosimilars Market Gaining Traction Due to Cost-Effective Treatment OptionsBiosimilars Market Drivers and Trends The surge in chronic diseases such as cancer, diabetes, and autoimmune disorders has heightened the need for affordable therapeutic options. Biosimilars, being cost-effective alternatives to original biologic drugs, offer significant savings for healthcare systems and patients. Additionally, the expiration of patents for several blockbuster biologics...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
What Is the Market Outlook for Biosimilars in the Anticancer Drug Segment?Anticancer Drugs Market Poised for Robust Growth Through 2030 The global anticancer drugs market is experiencing significant expansion, with projections estimating an increase from USD 222.57 billion in 2023 to USD 495.07 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 12.1% during the forecast period. Curious to peek inside? Grab your sample copy of...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare